Real Life, Real PD Survey

Similar documents
Q1 What age are you?

WCPT COUNTRY PROFILE December 2017 SWEDEN

WCPT COUNTRY PROFILE December 2017 HUNGARY

WCPT COUNTRY PROFILE December 2017 SERBIA

Smokefree Policies in Europe: Are we there yet?

Engagement in language assessment / Regions of Europe

Alcohol-related harm in Europe and the WHO policy response

Where we stand in EFORT

European Status report on Alcohol and Health

Media Release. Inaugural study reveals that more than one in four women in European and Central Asian prisons locked up for drug offences

European status report on alcohol and health Leadership, awareness and commitment

Overview of drug-induced deaths in Europe - What does the data tell us?

PARALLELISM AND THE LEGITIMACY GAP 1. Appendix A. Country Information

Cross Border Genetic Testing for Rare Diseases

A report on the epidemiology of selected vaccine-preventable diseases in the European Region 30% 20% 10%

LEBANON. WCPT COUNTRY PROFILE December 2018

WHO REGIONAL OFFICE FOR EUROPE RECOMMENDATIONS ON INFLUENZA

DENMARK. WCPT COUNTRY PROFILE December 2018

RECOMMENDATIONS ON INFLUENZA VACCINATION DURING THE WINTER SEASON

The cancer burden in the European Union and the European Region: the current situation and a way forward

GERMANY. WCPT COUNTRY PROFILE December 2018

Highlighting in the WHO European Region:

Men & Health Work. Difference can make a difference Steve Boorman & Ian Banks RSPH Academy 2013

EUDY JUNIOR CAMP 2018 FIRST ANNOUNCEMENT

Inequalities in health: challenges and opportunities in Europe Dr Zsuzsanna Jakab WHO Regional Director for Europe

Biology Report. Is there a relationship between Countries' Human Development Index (HDI) level and the incidence of tuberculosis?

Highlighting in the WHO European Region: Summary. No. 21(February 2012)

Drinking guidelines used in the context of early identification and brief interventions in Europe: overview of RARHA survey results

508 the number of suicide deaths in deaths per 100,000 people was the suicide rate in Suicide deaths in 2013 by gender

World Health Organization Regional Office for Europe Surveillance of measles and rubella Data as of 15 March 2006

Development of Palliative Care services in different countries

The Risk of Alcohol in Europe. Bridging the Gap June 2004

European Community Pharmacy: a reference in Public Health

EURO POLIO PAGE Data as of 04 October 2005 (Week 38)

European Collaboration on Dementia. Luxembourg, 13 December 2006

ALCOHOL CONSUMPTION IN EUROPE; TRADITIONS, GENERATIONS, CULTURE AND POLICY

Situation update in the European Region: overview of influenza surveillance data week 40/2009 to week 07/2010.

Yersiniosis SURVEILLANCE REPORT. Annual Epidemiological Report for Key facts. Methods. Epidemiology

real-time AQ data 2007 and plans for 2008

Highlighting in the WHO European Region: measles outbreaks rubella surveillance acute flaccid paralysis surveillance

Where do EU Contries set the limit for low risk drinking.

Access to treatment and disease burden

Emerging Risks Mapping of Activities in Member States. 67th Advisory Forum meeting, Utrecht, The Netherlands, 6 February 2018

MEDICINES SHORTAGES PGEU GPUE. John Chave - Secretary general. Pharmaceutical Group of European Union Groupement Pharmaceutique de l Union Européenne

Manuel Cardoso RARHA Executive Coordinator Public Health MD Senior Advisor Deputy General-Director of SICAD - Portugal

Underage drinking in Europe

Rheumatoid Arthritis Disease Burden and Access to Treatment

Is there a relationship between Countries' Human Development Index (HDI) level and the incidence of tuberculosis?

Animal health situation of OIE Member Countries in Europe 1 st semester 2012 (and previous)

National Institute on Alcohol Abuse and Alcoholism. Environmental Approaches

We are here for our fellow patients

Perspectives for information on alcohol use in the EU

UK bowel cancer care outcomes: A comparison with Europe

Cost of Disorders of the Brain in Europe Gustavsson et al. Cost of disorders of the brain in Europe Eur. Neuropsych. (2011) 21,

The Identification of Food Safety Priorities using the Delphi Technique

EFSA s Concise European food consumption database. Davide Arcella Data Collection and Exposure Unit

Monthly measles and rubella monitoring report

TEDDY. Teddy Network of Excellence. Annagrazia ALTAVILLA. Ph.D. Sciences Ethics LL.M. Health Law. diterranée

EUDY CHILDREN CAMP 2017 FIRST ANNONUCEMENT

Prevention of Oral Cancer Special Interest Working Group

European Association of Dental Public Health Prevention of Oral Cancer

REPORT FROM THE COMMISSION TO THE EUROPEAN PARLIAMENT, THE COUNCIL, THE EUROPEAN ECONOMIC AND SOCIAL COMMITTEE AND THE COMMITTEE OF THE REGIONS

WELLNESS COACHING. Wellness & Personal Fitness Solution Providers

Note on the harmonisation of SILC and EHIS questions on health

Overview of European Consumption Databases

Long Term Forensic Psychiatric Care in the Netherlands. Peter Braun Pompestichting Nijmegen/Zeeland/Vught. 8th of November 2018

31 countries (117 registries, 20 national) Increased coverage in countries with regional registries 50% European population Overall >20 million

Burden and cost of alcohol, tobacco and illegal drugs globally and in Europe

Overall survival: 1 st line therapy

IOSH No Time to Lose campaign: working together to tackle asbestos-related cancer #NTTLasbestos. Jonathan Hughes IOSH Vice President

The health economic landscape of cancer in Europe

D7.1 Report summarising results of survey of EU countries to identify volumes and trends in relation to the import and export of stem cells

D7.1 Report summarising results of survey of EU countries to identify volumes and trends in relation to the import and export of stem cells

WEST NILE VIRUS AND OTHER MOSQUITO-BORNE DISEASE NATIONAL SURVEILLANCE REPORT

Europa Donna in Europe and in Slovenia

Summary. Primary care data. Week 49/2014. Season

Trichinellosis SURVEILLANCE REPORT. Annual Epidemiological Report for Key facts. Methods

Outcome of proficiency test on EIA serology

Differences make a Difference

Palliative nursing care of children and young people across Europe

Design and Analysis of a Cancer Prevention Trial: Plans and Results. Matthew Somerville 09 November 2009

Table 7.1 Summary information for lung cancer in Ireland,

Analysis of 3-dose oral/inactivated poliovirus vaccine (OPV3/IPV3) immunization coverage

11 Melanoma of the skin

SVERIGES DÖVAS UNGDOMSFÖRBUND (SDUF), SWEDISH YNAD

CNAPA Meeting Luxembourg September 2016

Joint Programming in Neurodegenerative Disease Research (JPND)

Summary of Results for Laypersons

What s s on the Menu in Europe? - overview and challenges in the first pan- European food consumption survey

Global Trade in Lightweight Coated Writing Paper TradeData International Pty Ltd ( Page 1 5/18/2015

Louisville '19 Attachment #69

Injecting trends in Austria including results of a systematic literature review on interventions aiming to influence the route of administration

Research paper: Legal treatment of the use of cannabis for medical purposes in the member states of the European Union

Transcription:

Real Life, Real PD Survey Final Pan-European Survey Results

Survey Objectives The survey was carried out to provide insights into the realities of living with PD and to highlight some of the symptoms of PD that are less widely discussed By looking at: Real life everyday concerns faced by people with PD Fundamental areas of daily living such as eating, dressing and emotional well being Effects of mood on relationships with family members and friends Problems associated with disturbances in sleeping through the night or waking up tired To illustrate 24-hours in the life of a person with PD The Real Life, Real PD survey was supported by GlaxoSmithKline

Survey Background Launched online via the European Parkinson s Disease Association (EPDA) website across 31 European countries in October 2007 Participating countries were Andorra, Armenia, Austria, Azerbaijan, Belgium, Bosnia, Bulgaria, Czech Republic, Denmark, Estonia, Faeroe Islands, Finland, France, Georgia, Germany, Ireland, Italy, Lithuania, Luxembourg, Netherlands, Norway, Portugal, Romania, Slovakia, Slovenia, Spain, Sweden, Switzerland, Turkey, Ukraine and the UK Questionnaire developed in partnership with a pan-european steering committee of PD experts Recruitment of people via local EPDA member organisations Interim data analysis at the end of November 2007, final data analysis at the end of February 2008, via an independent research company Local results disseminated to EPDA member organisations at the end of March 2008

Key Findings

Symptom Control Over two thirds of respondents did not feel in control of their symptoms over a 24 hour period Three out of four said that their PD affects their ability to function throughout the day 44% 34% 22% Rarely / Never Sometimes Always / Often Q. Does your PD affect your ability to function properly in the morning and throughout the day?

Medication Over half need to plan their day around the times they take their medication Not in control at all 9% Completely in control 30% In control sometimes 61% Q. Do you feel in control of your symptoms over a 24 hour period?

Daily Life 60% of respondents reported difficulties in maintaining balance Over half have problems washing, bathing and dressing Over half suffer memory loss as a result of their PD Nearly half reported problems with self-organisation and speaking 42% experience difficulties driving Over a third reported difficulties with eating and drinking

Sense of Wellbeing 42% of people with PD stated that their moods can negatively affect their relationships Anxiety, frustration and worry are the three most prevalent emotional symptoms experienced 50% 29% 13% 8% Q: Do your moods negatively affect your relationships with friends, colleagues and family members? Rarely / Never Sometimes Always / Often Not stated / applicable

Sleep Patterns Nearly three quarters of respondents experience difficulties in getting to sleep as a result of their PD 70% wake at least once during the night as a result of their PD Nearly a quarter of respondents rate the quality of their sleep as poor / very poor 59% 28% Q. How often do you wake during the night as a result of your PD? 11% 2% Rarely / Never One to three times Four plus times Not stated

What do People With PD Want? Q. Which areas would you like to improve most about your condition? Daily living activities Most important Feeling less tired Achieving a sense of wellbeing Sleeping through the night Being tied to a medication regime Relationships with family / friends Experiencing negative moods Least important

Conclusions The survey demonstrates that PD patients frequently experience problems in symptom control over a 24 hour period Strict medication regimes mean that patients often need to plan their day around the times they take their medication The unpredictability of PD affects patients ability to function throughout the day and can cause difficulties in performing everyday activities PD can also result in sleep problems and can have a negative impact on emotional wellbeing